¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"percent surface dose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® surface tension ÇÑ±Û Ç¥¸éÀå·Â
¼³¸í   
  ¾×üÀÇ ÀÚÀ¯Ç¥¸é¿¡¼­ Ç¥¸éÀ» ÀÛ°ÔÇÏ·Á°í ÀÛ¿ëÇϴ Àå·Â. ºñ´©¹æ¿ïÀ̳ª ¾×ü ¼ÓÀÇ ±âÆ÷-¹°¹æ¿ï µîÀÌ ±¸»óÀÌ µÇ´Â °ÍÀº ÀÌ ÈûÀÌ ¾×¸é¿¡ ÀÛ¿ëÇϱ⠶§¹®À̸ç, ¿ë±âÀÇ °¡ÀåÀÚ¸®¿¡ ¾×ü°¡ ³ÑÃÄ ¿Ã¶ó°£ ¸ð¾çÀÌ µÇ¾î ½ñ¾ÆÁöÁö ¾Ê´Â °Íµµ ¾×ü Ç¥¸é¿¡ Àå·ÂÀÌ ÀÛ¿ëÇϱ⠶§¹®ÀÌ´Ù. ¼ö¸é¿¡ ¶³¾î¶ß¸° ±â¸§¹æ¿ïÀÌ ±Ý¹æ ÆÛÁö´Â °ÍÀº ¹°ÀǠǥ¸éÀå·ÂÀÌ ±â¸§ÀǠǥ¸éÀå·Âº¸´Ù Å©°í, ±â¸§ÃþÀÌ ¹°ÀǠǥ¸éÀå·Â¿¡ ÀÇÇØ Àâ¾Æ ´Ã¿©Áö±â ¶§¹®ÀÌ´Ù.
¿µ¹® radiation dose ÇÑ±Û ¹æ»ç¼±·®
¼³¸í   
  ¹æ»ç¼±Á¶»çÀÇ Á¤µµ. ¹æ»ç¼±»ý¹°ÇÐÀ̳ª ÀÎüÀÇ ¹æ»ç¼±¹æÈ£¿¡¼­´Â Àü¸®¹æ»ç¼±ÀÇ ¾ç, Áï ¼±·®ÀÌ ¹®Á¦°¡ µÈ´Ù. ¹æ»ç¼±·®¿¡¼­µµ ±¹Á¦´ÜÀ§°è(SI)°¡ Ã¤¿ëµÇ¾î ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)ÀÇ ±Ç°í¿¡ µû¶ó¼­ ´ÙÀ½ÀÇ ¿©·¯ ´ÜÀ§°¡ ³Î¸® »ç¿ëµÈ´Ù. ¨ç Èí¼ö¼±·®(absorbed dose). ¹°ÁúÀÇ ´ÜÀ§Áú·®ÀÌ ¹æ»ç¼±¿¡ ÀÇÇØ ¹Þ¾ÆµéÀ̴ ¿¡³ÊÁö. ÀÌ ´ÜÀ§´Â ¹æ»ç¼± ¹× ¹°ÁúÀÇ Á¾·ù°¡ ¾î¶°ÇÑ °ÍÀÌ´õ¶óµµ »ç¿ëÇÒ ¼ö ÀÖ´Ù. ±¹Á¦´ÜÀ§´Â J/kgÀ̸ç À̰Ϳ¡ °íÀ¯ÇÑ ¸íĪÀ¸·Î ±×·¹ÀÌ(gray, ±âÈ£ Gy)°¡ ºÎ¿©µÈ´Ù. 1Gy=100¶óµå(rad). ¨è Á¶»ç¼±·®(exposure) ¶Ç´Â °øÁß¼±·®. X¼± ¶Ç´Â ¥ã¼±¿¡ ÇÑÇØ¼­ »ç¿ëµÈ´Ù. ±¹Á¦´ÜÀ§´Â C/kg. ¨é ¼±·®´ç·®(dose equivalent). ¹æ»ç¼±¹æÈ£¸¦ À§ÇØ »ç¿ëµÇ´Â ¾ç. ±âÈ£´Â H. H´Â ¹æ»ç¼±ÀÇ Á¾·ù¿Í ¿¡³ÊÁö¿¡ ÀÇÇØ »ýü¿¡ Áִ ȿ°ú¸¦ º¸Á¤Çϴ ¼±Áú°è¼ö(Q)¿Í ±× ¹ÛÀÇ ÀÎÀÚ(¿¹¸¦ µé¸é ¼±·®·ü, ¹æ»ç¼ºµ¿À§¿ø¼Ò¿¡ ÀÇÇÑ ³»ºÎÇÇÆø½Ã¿¡´Â ±× ÇÙÁ¾ÀǠü³»ºÐÆ÷ µî)¿¡ ±Ù°ÅÇÑ º¸Á¤°è¼ö(N)¸¦ Èí¼ö¼±·®(D)¿¡ °öÇÑ °Í, Áï H=D-Q-N. ¶ÇÇÑ DÀÇ ´ÜÀ§¸¦ Gy ¶Ç´Â rad·Î Ç¥½ÃÇÏ¿´À» ¶§ HÀÇ ´ÜÀ§¸¦ °¢°¢ ½Ãº£¸£Æ®(sievert, ±âÈ£ Sv) ¹× ·½(rem)À̶ó°í ÇÑ´Ù. µû¶ó¼­ 1 Sv=102rem. ÀϹÝÀûÀ¸·Î ´ÜÀ§½Ã°£´çÀÇ ¼±·®À» ¼±·®·ü(dose rate)À̶ó°í ÇÑ´Ù.
¿µ¹® dose ÇÑ±Û ¿ë·®, Åõ¿©·®, ¹æ»ç¼±·®
¼³¸í   
  1. ¾àÁ¦¸¦ ÇÑ ¹ø ¶Ç´Â ÇÏ·ç¿¡ »ç¿ëÇϰųª º¹¿ëÇϴ ºÐ·®. 2. ¹°ÁúÀ̳ª Á¶Á÷¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ÀÛ¿ë Á¤µµ¸¦ ³ªÅ¸³»´Â ¾ç. Áï, ¹æ»ç¼±·®À̶ó´Â °³³äÀº ¾î¶² ÇÑ Á¡¿¡ ÀÔ»çÇϴ ¹æ»ç¼±°ú ±× Á¡ ±Ùó¿¡ Àִ ¹°Áú¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ¹°¸®Àû-È­ÇÐÀû-»ý¹°ÇÐÀû È¿°ú¿ÍÀÇ °ü°Ô¸¦ Á¤·®ÀûÀ¸·Î ³ªÅ¸³»´Â °øÅëÀΠôµµ·Î¼­ »ý°¢µÈ °ÍÀÌ´Ù. ¶óµå(rad)·Î ³ªÅ¸³»´Â Èí¼ö·®, ·»Æ®°Õ(R)À¸·Î ³ªÅ¸³»´Â Á¶»ç ¼±·®, ·½(rem)À¸·Î ³ªÅ¸³»´Â ¼±·® ´ç·®À¸·Î ±¸ºÐÇÏ¿© ¾´´Ù.
¿µ¹® skin dose ÇÑ±Û ÇǺμ±·®
¼³¸í   
  1. ÇǺÎÇ¥¸é¿¡¼­ÀÇ ¹æ»ç¼±ÀÇ °øÁß¼±·®À¸·Î ¿©±â¿¡´Â 1Â÷¹æ»ç¼±°ú ÈĹæ»ê¶õÀÌ Æ÷ÇԵȴÙ. 2. ÇǺο¡ Èí¼öµÇ´Â ¼±·®.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percent labeled mitosis technique
    ¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿­¹ý
  • approximal surface
    Á¢Ã˸é, ÀÎÁ¢¸é
  • articular surface
    °üÀý¸é
  • body surface mapping
    üǥ¸éÀüÀ§Áöµµ
  • cardiac surface map
    ½ÉÀåÇ¥¸éµµ
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • dorsal surface
    µîÂʸé, µÞ¸é, ¹èÃø¸é
  • fetal surface
    žÆ(ÂÊ)¸é
  • free surface
    ÀÚÀ¯¸é
  • hepatitis B surface antigen
    BÇü°£¿°Ç¥¸éÇ׿ø
  • internal surface
    ¼Ó¸é, ³»¸é
  • lateral surface
    °¡Âʸé, ¿ÜÃø¸é, Ãø¸é
  • occlusal surface
    ±³ÇÕ¸é, ¸Â¹°¸²¸é
  • potential surface
    ÀüÀ§¸é
  • proximate surface
    ÀÎÁ¢¸é
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • surface antigen
    Ç¥¸éÇ׿ø
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
  • surface coil
    Ç¥¸éÄÚÀÏ, Ç¥¸é°ËÃâ±â
  • surface characteristic
    Ç¥¸éƯ¼º
  • surface electrode
    Ç¥¸éÀü±Ø
  • surface
    Ç¥¸é, ¸é
  • articular surface
    °üÀý¸é
  • dorsal surface
    µîÂʸé, µÞ¸é
  • lateral surface
    °¡Âʸé, ¿ÜÃø¸é
  • potential surface
    ÀüÀ§¸é
  • proximate surface
    ÀÎÁ¢¸é
  • surface tension
    Ç¥¸éÀå·Â
  • dose
    ¿ë·®, Åõ¿©·®, ¹æ»ç¼±·®
  • average dose
    Æò±Õ¿ë·®, Æò±Õ¼±·®
  • booster dose
    Ãß°¡Á¢Á¾·®, Ãß°¡¿ë·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percent labeled mitosis technique
    ¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿­¹ý
  • percent reactive antibody test
    ¹éºÐÀ²¹ÝÀÀÇ×ü°Ë»ç
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý¸é
  • hepatitis B surface antigen
    ºñÇü°£¿°Ç¥¸éÇ׿ø
  • surface anesthesia
    Ç¥¸é¸¶Ãë
  • surface antigen
    Ç¥¸éÇ׿ø
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
  • surface refrigeration anesthesia
    Ç¥¸é³Ãµ¿¸¶Ãë
  • body surface mapping
    üǥ¸éÀüÀ§µµ
  • cardiac surface map
    ½ÉÀåÇ¥¸éµµ
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • root surface cavity
    À̻Ѹ®¸é°ø°£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gram percent
    ±×·¥¹éºÐÀ²(¡­ÛÝÝÂëÒ).
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®, Áß°£À¯È¿·®.
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®.
  • ED 50=ÊÝeffective dose 50%
    50% À¯È¿·®.
  • ED=ÊÝeffective dose
    À¯È¿·®.
  • ID50 (50% infectious dose)
    50% °¨¿°·®
  • LD = lethal dose
    Ä¡»ç·®.
  • LD50 (50% lethal dose)
    50% Ä¡»ç·®
  • LD= lethal dose
    Ä¡»ç·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
  • MED=> minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MED=£¾minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MTD=> maximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=£¾maximum tolerance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=ÊÝmaximum toderance dose
    ÃÖ´ë³»¿ë·®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percent surface dose
    Ç¥¸é¼±·®¹éºÐÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gram percent
    ±×·¥¹éºÐÀ²(¡­ÛÝÝÂëÒ).
  • percent labeled mitoses technique
    ¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿­¹ý
  • percent reactive antibody test
    ÆÛ¼¾Æ®¹ÝÀÀ(Úãëë)Ç×ü°Ë»ç
  • volume percent
    ¿ëÀû¹éºÐÀ²(é»îÝÛÝÝÂëÒ).
  • volume percent
    ¿ëÀû¹éºÐÀ²(é»îÝÛÝÝÂëÒ)
  • weight/volume percent
    üÁß/¿ëÀû ·ü
  • weight/weight percent
    üÁß/üÁß ·ü
  • cumulative dose ; cumulate dose
    ´©Àû¿ë·®.
  • cumulative dose ; cumulate dose
    ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® , [¿¹¹æ] ÁýÀû¼±·®.
  • cumulative dose ; cumulate dose
    ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® .[¿¹¹æ]ÁýÀû¼±·®.
  • dose rate ; dosage rate ; dose per unit time
    ¹æ»ç ÀÓº´,ÇÙÀÇ,¾à¸®¼±·®·ü, ¿ë·®.
  • optimal dose ; optimum dose
    ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
  • optimal dose ; optimum dose
    ¹æ»ç [¾à¸®,ÇØºÎ,¿¹¹æ]ÃÖÀû·®, ÀûÁ¤·®(ËøËøËâ).
  • optimal dose ; optimum dose
    ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
  • surface absorbed dose
    Ç¥¸éÈí¼ö¼±·®
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Diaphragmatic surface
    °¡·Î¸·¸é
    [¿¾ ¿ë¾î] Ⱦ°Ý¸é
  • Lateral surface
    °¡Âʸé
    [¿¾ ¿ë¾î] ¿ÜÃø¸é
  • Lateral surface
    °¡Âʸé
    [¿¾ ¿ë¾î] ¿ÜÃø¿¬
  • Malleolar articular surface
    °¡Âʺ¹»ç°üÀý¸é
    [¿¾ ¿ë¾î] ¿Ü°ú°üÀý¸é
  • Lateral malleolar surface
    °¡Âʺ¹»ç¸é
    [¿¾ ¿ë¾î] ¿Ü°ú¸é
  • Costal surface
    °¥ºñ¸é
    [¿¾ ¿ë¾î] ´Á°ñ¸é
  • Articular surface of tubercle
    °¥ºñ»À°áÀý°üÀý¸é
    [¿¾ ¿ë¾î] ´Á°ñ°áÀý°üÀý¸é
  • Articular surface of head of rib
    °¥ºñ»À¸Ó¸®°üÀý¸é
    [¿¾ ¿ë¾î] ´Á°ñµÎ°üÀý¸é
  • Pelvic surface
    °ñ¹Ý¸é
    [¿¾ ¿ë¾î] Àü¸é
  • Temporal surface
    °üÀÚ¸é
    [¿¾ ¿ë¾î] ÃøµÎ¸é
  • Infratemporal surface
    °üÀھƷ¡¸é
    [¿¾ ¿ë¾î] ÃøµÎÇϸé
  • Articular surface
    °üÀý¸é
    [¿¾ ¿ë¾î] °üÀý¸é
  • Posterior surface
    °üÀý¸é
    [¿¾ ¿ë¾î] °üÀý¸é
  • Occlusal surface
    ±³ÇÕ¸é
    [¿¾ ¿ë¾î] ±³ÇÕ¸é
  • Auricular surface
    ±Í¸ð¾ç¸é
    [¿¾ ¿ë¾î] ÀÌ»ó¸é
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable surface glycoprotein (VSG)
    º¯À̼ºÇ¥¸é´ç´Ü¹éÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atomic percent excess
    °ú´Ù ¿øÀÚ¹éºÐÀ²(ΦÒýê«í­ÛÝÝÂëÒ)
  • mg percent
    mg ÆÛ¼¾Æ®
  • milligram percent
    ¹Ð¸®±×¶÷ ÆÛ¼¾Æ®
  • mole percent
    ¸ô ÆÛ¼¾Æ®
  • percent ionization
    ÀÌ¿ÂÈ­(ûù) ÆÛ¼¾Æ®
  • percent saturation
    Æ÷È­µµ(øéûúÓø)
  • percent solution
    ÆÛ¼¾Æ® ¿ë¾×(éÁäû)
  • percent transmittance
    ÆÛ¼¾Æ® Åõ°úµµ(÷âÎ¦Óø)
  • contact surface
    Á¢Ã˸é(ïÈõºØü)
  • hepatitis B surface antigen
    BÇü(úþ) °£¿°(ÊÜæú) Ç¥¸é Ç׿ø(øúØüù÷ê«)
  • mixed surface film
    È¥ÇÕÇ¥¸é(ûèùêøúØü)Çʸ§
  • molecular surface
    ºÐÀÚÇ¥¸é(ÝÂí­øúØü)
  • reentrant surface
    ¿ä°¢ Ç¥¸é(èêÊÇøúØü)
  • surface-active agent
    Ç¥¸éȰ¼ºÁ¦ (øúØüüÀàõð¥)
  • surface activity
    Ç¥¸éȰ¼º (øúØüüÀàõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • depth resolved surface coil spectroscopy [=DRESS]
    ±íÀÌÇØ°áÇ¥¸éÄÚÀϺб¤¹ý
  • free surface
    ÀÚÀ¯¸é
  • malleolar articular surface
    ³»°ú°üÀý¸é, ³»Ãøº¹»ç°üÀý¸é
  • medial surface
    ³»Ãø¸é
  • outer surface
    ¿ÜÃøÇ¥¸é
  • quadrature surface coil
    ±¸ÀûÇ¥¸éÄÚÀÏ
  • shade surface display
    ±×¸²ÀÚÇ¥¸éÇ¥½Ã
  • smooth surface
    ÆòȰ¸é
  • SSD [=shade surface display]
    ±×¸²ÀÚÇ¥¸éÇ¥½Ã
  • surface
    Ç¥¸é
  • surface coil
    Ç¥¸éÄÚÀÏ, Ç¥¸é°ËÃâ±â
  • surface rendering mode
    Ç¥¸é¿¬Ãâ¹æ½Ä
  • symphysial surface
    Ä¡°ñ°áÇÕ¸é
  • tuning of surface coil
    Ç¥¸é ÄÚÀÏÁ¶À², Ç¥¸é°ËÃâ±âÁ¶Á¤
  • ventromedial surface
    ³»ÃøÀü¸é, º¹³»Ãø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
TD tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus...
SSD shaded surface display; single saturating dose; Social Security disability; source-skin distance; so...
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
LD labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PLM Percent Labeled Mitosis
4 percent patient
ESD Entrance surface dose
BMD Benchmark dose
BED Biologically Effective Dose
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • percent reactive antibody test
    ÆÛ¼¾Æ® ¹ÝÀÀ Ç×ü °Ë»ç
  • weight/volume percent
    üÁß/¿ëÀû ·ü
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
  • air dose
    °øÁß ¼±·®, °ø±âÁß ¼±·®
    ´Ù¸¥ ¹°Ã¼¿¡ ÀÇÇÑ »ê¶õ¼±À» Á¦¿ÜÇÑ °ø±â ÁßÀÇ ¼±·®. ÀϹÝÀûÀ¸·Î ¹°Ã¼ÀÇ Ç¥¸é¿¡ À־µµ, ¶Ç´Â »ýü Á¶Á÷ ³»ÀÇ ÀÏ Á¡¿¡¼­ÀÇ ¼±·®À¸·Î¼­µµ ¸ðµç »ê¶õ¼±ÀÇ ¿µÇâÀ» ¹Þ±â ¶§¹®¿¡ °øÁß ¼±·®º¸´Ù ¸¹¾ÆÁø´Ù.
  • average dose
    Æò±Õ ¿ë·®, Æò±Õ Á¶»ç·®
  • average maintenance dose
    µð±âÅ»¸®½º Æò±Õ À¯Áö·®
  • basal dose
    ±âº» ¼±·®
  • booster dose
    Ãß°¡ Á¢Á¾·®
  • committed effective dose equivalent
    ¿¹Å¹ À¯È¿ ¼±·® ´ç·®
  • cumulative absorbed dose
    ´©Àû ¼±·®, ´©Àû Èí¼ö¼±·®
  • cumulative dose
    ÁýÀû ¼±·®, ´©Àû Á¶»ç·®, ´©Àû ¿ë·®, Ãàô ¿ë·®
  • curative dose
    ġȿ·®
  • daily dose
    ÀÏÀÏ·®, ÀϿ뷮
  • dose calculation
    ¼±·® °è»ê
  • dose commitment
    ¼±·® ¿¹Å¹
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
absorbed dose The amount of energy absorbed per unit mass of irradiated material at the target site; in radiation therapy, the former unit for absorbed dose is the rad; the current (S.I.) unit is the gray.
(05 Mar 2000)
air dose The radiation dose, expressed in roentgens, delivered at a point in free air.
Synonym: air dose.
(05 Mar 2000)
bone marrow dose The cumulative dose to the blood-forming organ from therapeutic or nuclear fallout irradiation; the presumed leukemogenic dose.
(05 Mar 2000)
booster dose A dose given at some time after an initial dose to enhance the effect, said usually of antigens for the production of antibodies.
(05 Mar 2000)
breast dose in mammography <radiology> 180 mrad / view -- mid-breast dose, guideline: less than 1 rad for 2-view exam
(12 Dec 1998)
maintenance dose In chemotherapy, systematic dosage at a level that maintains protection against exacerbation.
(05 Mar 2000)
genetically significant dose <physics, radiobiology> The genetically significant dose is that which, if received by every member of the population, would be expected to produce the same genetic injury to the population as do the actual doses received by the individuals irradiated.
Thus, the genetically significant dose is the dose equivalent to the gonads weighted for the age and sex distribution in those members of the irradiated population expected to have offspring. The genetically significant dose is expressed in sieverts (or rem).
Acronym: GSD
(06 Aug 1998)
maximal dose <pharmacology> The largest amount of a drug or physical procedure that an adult can take with safety.
(05 Mar 2000)
maximum permissible dose <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime.
This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large.
(05 Mar 2000)
median effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
gonadal dose The exposure dose to the male or female gonad, usually from incidental secondary radiation in diagnostic or therapeutic irradiation, or from whole-body irradiation.
Synonym: gonadal dose.
(05 Mar 2000)
gonad dose The exposure dose to the male or female gonad, usually from incidental secondary radiation in diagnostic or therapeutic irradiation, or from whole-body irradiation.
Synonym: gonadal dose.
(05 Mar 2000)
minimal dose <pharmacology> The smallest amount of a drug or physical procedure that will produce a desired physiologic effect in an adult.
(05 Mar 2000)
minimal infecting dose <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures).
(05 Mar 2000)
minimal lethal dose <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation).
When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05.
See: lethal dose.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percent
    ÆÛ¼¾Æ®(%)
  • percent
    ÆÛ¼¾Æ®;100ºÐ
  • dose
    ¾àÀÇ 1ȸºÐ;~¿¡ Åõ¾àÇÏ´Ù;º¹¿ë½ÃŰ´Ù
  • maximum dose
    (¾àÀÇ) ±Ø·®
  • minimum dose
    ÃÖ¼Ò Åõ¾à·®
  • air-to-surface
    °ø´ëÁöÀÇ
  • surface
    Ç¥¸é,Ç¥¸éÀÇ
  • imposing stone(table,surface)
    (ÀÎ)Á¤ÆÇ´ë
  • surface
    Ç¥¸éÀ» ºÙÀÌ´Ù;ÆÇÆÇÇÏ°Ô ÇÏ´Ù;Æ÷ÀåÇÏ´Ù
  • surface
    na;Ç¥¸é(ÀÇ);¿Ü°ü(ÀÇ);°Ñº¸±â(»ÓÀÇ);¸é
  • surface car
    ³ë¸é ÀüÂ÷
  • surface mail
    (Ç×°ø ¿ìÆí¿¡ ´ëÇÏ¿©)Áö»ó ÇØ»ó ¼ö¼Û ¿ìÆí
  • surface noise
    (·¹ÄÚµåÀÇ)¹Ù´Ã ¼Ò¸® (ÀâÀ½)
  • surface printing
    ºí·ÏÆÇ Àμâ(³¯¿°)
  • surface tension
    Ç¥¸é Àå·Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á